Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1

G protein-coupled estrogen receptor 1 (GPER1) is a potential therapeutic target for treating triple-negative breast cancers (TNBC). However, modulators for GPER1 that can be used to treat TNBC have not appeared. Berberine (BBR) is a bioactive isoquinoline alkaloid with high oral safety. In recent ye...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Miaomiao Qi, Xiang Liu, Ying Zhou, Haoyu Wang, Ying Zhao, Jing Ren, Jin Xiang
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/07058c31455d4bdaa6655fe7ee9f56ec
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:07058c31455d4bdaa6655fe7ee9f56ec
record_format dspace
spelling oai:doaj.org-article:07058c31455d4bdaa6655fe7ee9f56ec2021-11-11T16:55:44ZBerberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 110.3390/ijms2221114661422-00671661-6596https://doaj.org/article/07058c31455d4bdaa6655fe7ee9f56ec2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11466https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067G protein-coupled estrogen receptor 1 (GPER1) is a potential therapeutic target for treating triple-negative breast cancers (TNBC). However, modulators for GPER1 that can be used to treat TNBC have not appeared. Berberine (BBR) is a bioactive isoquinoline alkaloid with high oral safety. In recent years, BBR has shown an inhibitory effect on TNBC tumors such as MDA-MB-231, but the molecular target remains unclear, which hinders related clinical research. Our work proved that BBR is a modulator of GPER1 that can inhibit cell viability, migration, and autophagy of MDA-MB-231 cells. The inhibitory effect of BBR on MDA-MB-231 cells has a dependence on estrogen levels. Although BBR promoted the proteasome, which is a major factor in the degradation of GPER1, it could still induce the protein level of GPER1. Correspondingly, the transcription of cellular communication network factor 2 (CCN2) was promoted. BBR could bind to GPER1 directly and change the secondary structure of GPER1, as in the case of 17β-estradiol (E2). In addition, BBR induced not only a high degree of co-localization of GPER1 and microtubule-associated protein 1 light chain 3 (MAP1LC3), but also the accumulation of sequestosome 1 (SQSTM1/p62) by the inhibition of the nuclear translocation of the nuclear factor-kappa B (NF-κB) subunit (RELA/p65), which indicates NF-κB inhibition and anti-cancer effects. This result proved that the promotional effect of BBR on the GPER1/NF-κB pathway was closely related to its inhibitory effect on autophagy, which may serve as a new mechanism by which to explain the inhibitory effect of BBR on MDA-MB-231 cells and expand our understanding of the function of both BBR and GPER1.Miaomiao QiXiang LiuYing ZhouHaoyu WangYing ZhaoJing RenJin XiangMDPI AGarticleberberinebindingco-localizationGPER1MAP1LC3NF-κBBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11466, p 11466 (2021)
institution DOAJ
collection DOAJ
language EN
topic berberine
binding
co-localization
GPER1
MAP1LC3
NF-κB
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle berberine
binding
co-localization
GPER1
MAP1LC3
NF-κB
Biology (General)
QH301-705.5
Chemistry
QD1-999
Miaomiao Qi
Xiang Liu
Ying Zhou
Haoyu Wang
Ying Zhao
Jing Ren
Jin Xiang
Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1
description G protein-coupled estrogen receptor 1 (GPER1) is a potential therapeutic target for treating triple-negative breast cancers (TNBC). However, modulators for GPER1 that can be used to treat TNBC have not appeared. Berberine (BBR) is a bioactive isoquinoline alkaloid with high oral safety. In recent years, BBR has shown an inhibitory effect on TNBC tumors such as MDA-MB-231, but the molecular target remains unclear, which hinders related clinical research. Our work proved that BBR is a modulator of GPER1 that can inhibit cell viability, migration, and autophagy of MDA-MB-231 cells. The inhibitory effect of BBR on MDA-MB-231 cells has a dependence on estrogen levels. Although BBR promoted the proteasome, which is a major factor in the degradation of GPER1, it could still induce the protein level of GPER1. Correspondingly, the transcription of cellular communication network factor 2 (CCN2) was promoted. BBR could bind to GPER1 directly and change the secondary structure of GPER1, as in the case of 17β-estradiol (E2). In addition, BBR induced not only a high degree of co-localization of GPER1 and microtubule-associated protein 1 light chain 3 (MAP1LC3), but also the accumulation of sequestosome 1 (SQSTM1/p62) by the inhibition of the nuclear translocation of the nuclear factor-kappa B (NF-κB) subunit (RELA/p65), which indicates NF-κB inhibition and anti-cancer effects. This result proved that the promotional effect of BBR on the GPER1/NF-κB pathway was closely related to its inhibitory effect on autophagy, which may serve as a new mechanism by which to explain the inhibitory effect of BBR on MDA-MB-231 cells and expand our understanding of the function of both BBR and GPER1.
format article
author Miaomiao Qi
Xiang Liu
Ying Zhou
Haoyu Wang
Ying Zhao
Jing Ren
Jin Xiang
author_facet Miaomiao Qi
Xiang Liu
Ying Zhou
Haoyu Wang
Ying Zhao
Jing Ren
Jin Xiang
author_sort Miaomiao Qi
title Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1
title_short Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1
title_full Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1
title_fullStr Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1
title_full_unstemmed Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1
title_sort berberine inhibits mda-mb-231 cells as an agonist of g protein-coupled estrogen receptor 1
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/07058c31455d4bdaa6655fe7ee9f56ec
work_keys_str_mv AT miaomiaoqi berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1
AT xiangliu berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1
AT yingzhou berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1
AT haoyuwang berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1
AT yingzhao berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1
AT jingren berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1
AT jinxiang berberineinhibitsmdamb231cellsasanagonistofgproteincoupledestrogenreceptor1
_version_ 1718432159840075776